Growth Metrics

Glucotrack (GCTK) Cost of Revenue (2016 - 2025)

Glucotrack (GCTK) reported Cost of Revenue of $120000.0 for Q3 2025, down 4.0% year-on-year from $125000.0 in Q3 2024, and down 34.07% quarter-over-quarter from $182000.0 in Q2 2025.

Glucotrack (GCTK) has 8 years of Cost of Revenue data on file, last reported at $120000.0 in Q3 2025.

  • For the quarter ending Q3 2025, Cost of Revenue fell 4.0% year-over-year to $120000.0; the trailing twelve-month figure through Sep 2025 stood at $555000.0 (up 86.24% YoY), and the FY2023 full-year result was $122000.0, changed N/A from the prior year.
  • Cost of Revenue for Q3 2025 stood at $120000.0, down from $182000.0 in the prior quarter.
  • Across five years, Cost of Revenue topped out at $182000.0 in Q2 2025 and bottomed at $3000.0 in Q4 2021.
  • A 3-year average of $96000.0 and a median of $113000.0 in 2021 frame the typical range for Cost of Revenue.
  • Peak annual rise in Cost of Revenue reached 108.11% in 2021, while the deepest fall reached 74.73% in 2021.
  • Tracing GCTK's Cost of Revenue over 3 years: stood at $3000.0 in 2021, then jumped by 4066.67% to $125000.0 in 2024, then slipped by 4.0% to $120000.0 in 2025.
  • According to Business Quant data, Cost of Revenue over the past three periods registered $120000.0, $182000.0, and $128000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 940.30 Mn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 2.56 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 540.43 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 548.50 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 64.00 Mn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 328.90 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 303.50 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 1.81 Bn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 630.96 Mn
10 Glucotrack 290,858.33 -7.09 Mn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 120,000.00
Sep 30, 2025 120,000.00
Jun 30, 2025 182,000.00
Jun 30, 2025 182,000.00
Mar 31, 2025 128,000.00
Mar 31, 2025 128,000.00
Sep 30, 2024 125,000.00
Sep 30, 2024 125,000.00
Jun 30, 2024 100,000.00
Jun 30, 2024 100,000.00
Mar 31, 2024 70,000.00
Mar 31, 2024 70,000.00
Dec 31, 2021 3,000.00
Dec 31, 2021 3,000.00
Sep 30, 2021 113,000.00
Sep 30, 2021 113,000.00
Mar 31, 2021 23,000.00
Mar 31, 2021 23,000.00
Dec 31, 2020 -37,000.00
Dec 31, 2020 -37,000.00
Sep 30, 2020 93,000.00
Sep 30, 2020 93,000.00
Jun 30, 2020 90,000.00
Jun 30, 2020 90,000.00
Mar 31, 2020 91,000.00
Mar 31, 2020 91,000.00
Dec 31, 2019 128,445.00
Dec 31, 2019 128,445.00
Sep 30, 2019 168,259.00
Sep 30, 2019 168,259.00
Jun 30, 2019 150,953.00
Jun 30, 2019 150,953.00
Mar 31, 2019 125,343.00
Mar 31, 2019 125,343.00
Dec 31, 2018 235,076.00
Dec 31, 2018 235,076.00
Sep 30, 2018 265,282.00
Sep 30, 2018 265,282.00
Jun 30, 2018 283,467.00
Jun 30, 2018 283,467.00
Mar 31, 2018 308,637.00
Mar 31, 2018 308,637.00
Dec 31, 2017 461,120.00
Dec 31, 2017 461,120.00
Sep 30, 2017 465,814.00
Sep 30, 2017 465,814.00
Jun 30, 2017 361,295.00
Jun 30, 2017 361,295.00
Mar 31, 2017 236,939.00
Mar 31, 2017 236,939.00
Dec 31, 2016 -916,663.00
Dec 31, 2016 -916,663.00
Sep 30, 2016 325,143.00
Sep 30, 2016 325,143.00
Jun 30, 2016 349,804.00
Jun 30, 2016 349,804.00
Mar 31, 2016 313,395.00
Mar 31, 2016 313,395.00